Clinical Trial Update: Simvastatin in the Prevention of Recurrent Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating simvastatin to prevent recurrent pancreatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Enrique de-Madaria | Conditions: Pancreatitis Relapsing | Phase 3 | Status: TERMINATED